Opioid maker Purdue Pharma is preparing to shut down as part of a groundbreaking $7.4 billion settlement addressing its role in the devastating opioid crisis. This historic agreement will deliver crucial funds straight to communities nationwide that have been deeply affected by the epidemic
More than 100 lives have been heartbreakingly lost due to fentanyl contamination in Argentine hospitals, igniting urgent concerns over drug safety and hospital protocols. Authorities are racing to uncover the source and assess the full scale of this devastating crisis
In this opinion piece, The Globe and Mail argues that Canada should not be held responsible for America’s fentanyl crisis. It dives into the complex factors driving the epidemic and urges for enhanced cross-border cooperation instead of assigning blame
The dialogue around Canada’s opioid crisis is transforming, moving away from stigma and embracing a more compassionate approach centered on treatment. With overdose rates climbing alarmingly, policymakers and advocates are rallying for innovative solutions that emphasize harm reduction and robust mental health support.
A recent investigation by BBC reveals that an Indian pharmaceutical company is significantly contributing to West Africa’s escalating opioid crisis. The report highlights alarming practices, including the production and distribution of potent opioids, raising concerns about public health and regulatory oversight in the region.
